Tumor metabolism as modulator of immune response and tumor progression.

Abstract:

:About a century ago Otto Warburg observed that tumor cells exhibited increased glycolysis despite the presence of oxygen and stated this metabolic shift to glycolysis as the origin of cancer cell. In the meantime it has become clear, that the altered glucose metabolism is only one piece of the tumor metabolome puzzle. In addition, amino acid, lipid and adenosine metabolism are adapted to fulfill the tumors needs for energy and generation of building blocks such as lipids and nucleotides for new cell structures. The altered tumor metabolism leads to accumulation of specific metabolites in the tumor environment and creates a favorable milieu for tumor growth, progression and metastasis. These tumor-derived metabolites are important players in immune escape mechanisms beside other known factors such as cytokines, chemokines and growth factors. A variety of metabolites re-educate immune cells and prevent an effective immune response against tumor cells. Furthermore, tumor infiltrating immune cells support tumor growth by the secretion of cytokines, growth factors and other metabolic determinants. Hence, a complex interplay of tumor metabolites, cytokines and stromal factors is active in tumors and facilitates their establishment and growth. Pharmacological blockade of tumor metabolites could overcome some limitations of cancer treatment and rescue the endogenous immune response against tumor cells.

journal_name

Semin Cancer Biol

authors

Gottfried E,Kreutz M,Mackensen A

doi

10.1016/j.semcancer.2012.02.009

subject

Has Abstract

pub_date

2012-08-01 00:00:00

pages

335-41

issue

4

eissn

1044-579X

issn

1096-3650

pii

S1044-579X(12)00045-4

journal_volume

22

pub_type

杂志文章,评审
  • Predicting liver metastases growth patterns: Current status and future possibilities.

    abstract::Colorectal cancer is highly incident worldwide and presents a health burden with elevated mortality rate despite prevention, detection, and treatment, mainly due to metastatic liver disease. Histological growth patterns of colorectal cancer liver metastases have emerged as a reproducible prognostic factor, with biolog...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章

    doi:10.1016/j.semcancer.2020.07.007

    authors: Oliveira RC,Alexandrino H,Cipriano MA,Alves FC,Tralhão JG

    更新日期:2020-07-14 00:00:00

  • Evolving paradigms in multifocal breast cancer.

    abstract::The 7th edition of the TNM defines multifocal breast cancer as multiple simultaneous ipsilateral and synchronous breast cancer lesions, provided they are macroscopically distinct and measurable using current traditional pathological and clinical tools. According to the College of American Pathologists (CAP), the chara...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2014.07.002

    authors: Salgado R,Aftimos P,Sotiriou C,Desmedt C

    更新日期:2015-04-01 00:00:00

  • Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence.

    abstract::Data accumulating during the last two decades suggest that tumorigenesis is held in check by two major intrinsic failsafe mechanisms; apoptosis and cellular senescence. While apoptosis is a programmed cell death process, cellular senescence, which is the focus of this article, is defined as irreversible cell cycle arr...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2011.10.005

    authors: Larsson LG

    更新日期:2011-12-01 00:00:00

  • Role of cell surface proteoglycans in cancer immunotherapy.

    abstract::Over the past few decades, understanding how tumor cells evade the immune system and their communication with their tumor microenvironment, has been the subject of intense investigation, with the aim of developing new cancer immunotherapies. The current therapies against cancer such as monoclonal antibodies against ch...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.07.012

    authors: Espinoza-Sánchez NA,Götte M

    更新日期:2020-05-01 00:00:00

  • CRISPR/Cas mediated epigenome editing for cancer therapy.

    abstract::The understanding of the relationship between epigenetic alterations, their effects on gene expression and the knowledge that these epigenetic alterations are reversible, have opened up new therapeutic pathways for treating various diseases, including cancer. This has led the research for a better understanding of the...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章

    doi:10.1016/j.semcancer.2020.12.018

    authors: Ansari I,Chaturvedi A,Chitkara D,Singh S

    更新日期:2021-01-06 00:00:00

  • The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis.

    abstract::Recently, work on the mechanism of action of the von Hippel-Lindau tumour suppressor protein (pVHL) and studies on hypoxic gene regulation have converged, providing insights into both cellular oxygen sensing and cancer pathogenesis. pVHL is the recognition component of the E3-ubiquitin ligase complex involved in the d...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/s1044-579x(02)00103-7

    authors: Pugh CW,Ratcliffe PJ

    更新日期:2003-02-01 00:00:00

  • Targeting the ubiquitin-proteasome system to activate wild-type p53 for cancer therapy.

    abstract::Ubiquitination plays a key role in regulating the tumour suppressor p53. It targets p53 for degradation by the 26S proteasome. The ubiquitin pathway also regulates the activity and localisation of p53. Ubiquitination requires ubiquitin-activating and -conjugating enzymes and ubiquitin ligases. In addition, ubiquitinat...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2009.10.004

    authors: Allende-Vega N,Saville MK

    更新日期:2010-02-01 00:00:00

  • Endogenous opiates, opioids, and immune function: evolutionary brokerage of defensive behaviors.

    abstract::Recent empirical data have elucidated a compelling physiological basis for endogenously expressed, chemically authentic, morphine and its cognate mu3 and mu4 opiate receptors. Cellular "morphinergic" signaling is predominantly targeted to autocrine/paracrine regulatory processes and is reciprocally linked to stimulate...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2007.12.001

    authors: Stefano GB,Kream R

    更新日期:2008-06-01 00:00:00

  • The weight of obesity in breast cancer progression and metastasis: Clinical and molecular perspectives.

    abstract::The escalating epidemic of overweight and obesity is currently recognized as one of the most significant health and economic concern worldwide. At the present time, over 1.9 billion adults and more than 600 million people can be, respectively, classified as overweight or obese, and numbers will continue to increase in...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.09.001

    authors: Barone I,Giordano C,Bonofiglio D,Andò S,Catalano S

    更新日期:2020-02-01 00:00:00

  • Harnessing serotonergic and dopaminergic pathways for lymphoma therapy: evidence and aspirations.

    abstract::Growing evidence supports the notion that pharmaceutical targeting of the 5-hydroxytryptamine (5-HT) and dopamine (DA) systems offers the potential to treat human immune system disorders. This review describes this emerging area of research, which has the benefit of being supported by a relatively detailed understandi...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2007.12.007

    authors: Barnes NM,Gordon J

    更新日期:2008-06-01 00:00:00

  • Clinical significance of the Thomsen-Friedenreich antigen.

    abstract::What is the clinical significance of the expression by common human carcinomas of the Thomsen-Friedenreich (TF) antigen? Described as a terminal disaccharide which is a precursor of MN blood group antigens, it was discovered as a laboratory curiosity 60 years ago, yet its cancer-association has only been appreciated i...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: MacLean GD,Longenecker BM

    更新日期:1991-12-01 00:00:00

  • Carbohydrate antigens on cancer-associated mucin-like molecules.

    abstract::Mucins are large molecular weight glycoproteins characterized by carbohydrate sugars attached via 'O-glycosidic' linkages to serine or threonine. Mucins are synthesized by a variety of epithelial tissues as membrane-bound or secreted proteins, encoded by several distinct mucin genes. Numerous alterations of mucin-asso...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: Ho SB,Kim YS

    更新日期:1991-12-01 00:00:00

  • Hyaluronidases in cancer biology.

    abstract::Hyaluronan is a megadalton glycosaminoglycan polymer critical for maintaining the integrity of the extracellular matrix. It can exist in a protein-bound state with aggregating proteoglycans, where it expands the extracellular matrix and modulates cell-cell interactions. It also exists in lower molecular weight forms t...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2008.03.017

    authors: Stern R

    更新日期:2008-08-01 00:00:00

  • Growing evidence that several human cancers may originate in utero.

    abstract::Hormone-related cancers may originate in utero. Accumulating evidence is given by animal studies, descriptive epidemiologic data and analytic etiologic studies. Indicators of high levels of endogenous pregnancy hormones, like high birth weight and jaundice in the offspring, are associated with increased risk for breas...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.1998.0073

    authors: Ekbom A

    更新日期:1998-08-01 00:00:00

  • Xenophagy in cancer.

    abstract::Macroautophagy (herein autophagy) is an intracellular pathway in which cytoplasmic components are captured by double-membrane vesicles (autophagosomes) that eventually fuse with lysosomes to degrade the cargo. Basal levels of autophagy in all eukaryotic cells maintain cellular homeostasis and under conditions of stres...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章

    doi:10.1016/j.semcancer.2020.02.015

    authors: Ammanathan V,Vats S,Abraham IM,Manjithaya R

    更新日期:2020-11-01 00:00:00

  • MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation.

    abstract::The discovery of microRNAs (miRNAs) is one of the major scientific breakthroughs in recent years and has revolutionized the way we look at gene regulation. Although we are still at a very early stage in understanding their impact on immunity, miRNAs are changing the way we think about the development of the immune sys...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2008.01.005

    authors: Sonkoly E,Ståhle M,Pivarcsi A

    更新日期:2008-04-01 00:00:00

  • The emerging roles of F-box proteins in pancreatic tumorigenesis.

    abstract::The role of F-box proteins in pancreatic tumorigenesis is emerging owing to their pivotal and indispensable roles in cell differentiation, cell cycle regulation and proliferation. In this review, we will focus on β-TrCP (β-transducin repeat-containing protein) and two other prototypical mammalian F-box proteins, Fbxw7...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2015.09.004

    authors: Wang H,Maitra A,Wang H

    更新日期:2016-02-01 00:00:00

  • Genetic dissection of melanoma pathways in the mouse.

    abstract::The frequent loss of the INK4a/ARF locus, encoding for both p16(INK4a)and p19(ARF)in human melanoma, raises the question as to which INK4a/ARF gene product functions to suppress melanoma-genesis in vivo. Studies in the mouse have shown that activated RAS mutation can cooperate with INK4a(Delta 2/3)deficiency (null for...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.2000.0376

    authors: Yang FC,Merlino G,Chin L

    更新日期:2001-06-01 00:00:00

  • Current and future systemic treatments for renal cell carcinoma.

    abstract::Systemic treatment of renal cell carcinoma has changed dramatically since 2007, with the development and approval of six new agents, which target complex molecular pathways regulating tumour angiogenesis and cell proliferation and survival. These treatments have significantly improved survival times in metastatic rena...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2012.06.004

    authors: Fisher R,Gore M,Larkin J

    更新日期:2013-02-01 00:00:00

  • Higher grade transformation of follicular lymphoma: phenotypic tumor progression associated with diverse genetic lesions.

    abstract::Higher grade histological transformation of follicular lymphoma (FL) to more aggressive diffuse large B-cell lymphomas (DLBCL) occurs in 10-60% of the cases. Review of the current knowledge of genetic and molecular alterations associated with the higher grade transformation of FCL suggests that the process that leads ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/s1044-579x(03)00015-4

    authors: Lossos IS,Levy R

    更新日期:2003-06-01 00:00:00

  • Cathepsin B and cystatins: evidence for a role in cancer progression.

    abstract::The cysteine proteinase cathepsin B has been implicated in the progression of tumors from a premalignant to a malignant state. Activity of cathepsin B has been shown to be elevated in parallel with malignancy or metastatic potential of human and rodent tumors. These increases in cathepsin B activity correspond in part...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: Sloane BF

    更新日期:1990-04-01 00:00:00

  • SV40 and the pathogenesis of mesothelioma.

    abstract::Malignant mesothelioma, a tumor of the pleura, pericardium, and peritoneum, is presently a worldwide problem. Current therapy is ineffective in slowing the course of the disease, and median survival from the time of diagnosis is rarely greater than 1 year. While the tumor was almost unknown prior to the second half of...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.2000.0347

    authors: Rizzo P,Bocchetta M,Powers A,Foddis R,Stekala E,Pass HI,Carbone M

    更新日期:2001-02-01 00:00:00

  • Carcinoma-associated fibroblasts provide operational flexibility in metastasis.

    abstract::Malignant cancer cells do not act as lone wolves to achieve metastasis, as they exist within a complex ecosystem consisting of an extracellular matrix scaffold populated by carcinoma-associated fibroblasts (CAFs), endothelial cells and immune cells. We recognize local (primary tumor) and distant ecosystems (metastasis...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2013.12.009

    authors: De Wever O,Van Bockstal M,Mareel M,Hendrix A,Bracke M

    更新日期:2014-04-01 00:00:00

  • Hypoxia driven glycation: Mechanisms and therapeutic opportunities.

    abstract::Tumor masses are deprived of oxygen and characterized by enhanced glucose uptake followed by glycolysis. Elevated glucose levels induce non-enzymatic glycosylation or glycation of proteins which leads to accumulation of advanced glycation end products (AGE). These AGE molecules bind to their respective receptors calle...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2017.05.008

    authors: Khan MI,Rath S,Adhami VM,Mukhtar H

    更新日期:2018-04-01 00:00:00

  • Nanotechnology, in silico and endocrine-based strategy for delivering paclitaxel and miRNA: Prospects for the therapeutic management of breast cancer.

    abstract::Breast cancer is one of the most prevalent and reoccurring cancers and the second most common reason of death in women. Despite advancements in therapeutic strategies for breast cancer, early tumor recurrence and metastasis in patients indicate resistance to chemotherapeutic medicines, such as paclitaxel due to the ab...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.12.022

    authors: Ansari MA,Thiruvengadam M,Farooqui Z,Rajakumar G,Sajid Jamal QM,Alzohairy MA,Almatroudi A,Alomary MN,Chung IM,Al-Suhaimi EA

    更新日期:2019-12-28 00:00:00

  • Targeting T cells for GVHD therapy.

    abstract::Bone marrow transplantation is currently used to treat a variety of life-threatening diseases. Its applications could be expanded if the risks of graft-versus-host disease (GVHD), a complex pathologic disease, could be reduced. Immunotoxins may provide a means to control drug refractory GVHD. This article will discuss...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.1996.0009

    authors: Vallera DA

    更新日期:1996-04-01 00:00:00

  • Drug repurposing for cancer therapy, easier said than done.

    abstract::Drug repurposing for cancer therapy is currently a hot topic of research. Theoretically, in contrast to the known hurdles of developing new molecular entities, the approach of repurposing has several advantages. Mostly, it is said that it is faster, safer, easier, and cheaper. In the real world, however, there are onl...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.12.012

    authors: Gonzalez-Fierro A,Dueñas-González A

    更新日期:2019-12-23 00:00:00

  • Mitogen-activated protein kinases in hepatocellular carcinoma development.

    abstract::Hepatocellular carcinoma (HCC) is among the most frequently occurring cancers and the leading causes of cancer mortality worldwide. Identification of the signaling pathways regulating liver carcinogenesis is critical in developing novel chemoprevention and targeted therapies. Mitogen-activated protein kinases (MAPKs),...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2010.10.011

    authors: Min L,He B,Hui L

    更新日期:2011-02-01 00:00:00

  • Familial nasopharyngeal carcinoma.

    abstract::Nasopharyngeal carcinoma (NPC) has a striking geographical and ethnical distribution. It occurs with high frequency in southern China and Southeast Asia. Family clustering was also observed in NPC and a typical family with 15 NPC cases was introduced in this paper. Epidemiological and genetic studies have been carried...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/s1044579x02000871

    authors: Zeng YX,Jia WH

    更新日期:2002-12-01 00:00:00

  • Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications.

    abstract::The global burden of breast cancer (BC) is increasing significantly. This trend is caused by several factors such as late diagnosis, limited treatment options for certain BC subtypes, drug resistance which all lead to poor clinical outcomes. Recent research has reported the role of epigenetic alterations in the mechan...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章

    doi:10.1016/j.semcancer.2020.08.009

    authors: Sher G,Salman NA,Khan AQ,Prabhu KS,Raza A,Kulinski M,Dermime S,Haris M,Junejo K,Uddin S

    更新日期:2020-08-25 00:00:00